These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11750317)

  • 21. Combination effect of tacrolimus and FTY720 in liver transplantation in rats.
    Tamura A; Li XK; Funeshima N; Enosawa S; Amemiya H; Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2785-6. PubMed ID: 10578290
    [No Abstract]   [Full Text] [Related]  

  • 22. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    Transplant Proc; 1999; 31(1-2):1230-3. PubMed ID: 10083549
    [No Abstract]   [Full Text] [Related]  

  • 23. Sirolimus and FTY720: new approaches to transplant immunosuppression.
    Kahan BD
    Transplant Proc; 2002 Nov; 34(7):2520-2. PubMed ID: 12431509
    [No Abstract]   [Full Text] [Related]  

  • 24. Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients.
    Johnson TA; Shames I; Keezer M; Lapierre Y; Haegert DG; Bar-Or A; Antel J
    Clin Immunol; 2010 Oct; 137(1):15-20. PubMed ID: 20599429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation.
    Xu M; Pirenne J; Antoniou S; Gunson B; D'Silva M; McMaster P
    Transplant Proc; 1998 Aug; 30(5):2221-2. PubMed ID: 9723447
    [No Abstract]   [Full Text] [Related]  

  • 26. Current perspectives on FTY720.
    Martini S; Peters H; Böhler T; Budde K
    Expert Opin Investig Drugs; 2007 Apr; 16(4):505-18. PubMed ID: 17371198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD.
    Schuurman HJ; Menninger K; Audet M; Kunkler A; Maurer C; Vedrine C; Bernhard M; Gaschen L; Brinkmann V; Quesniaux V
    Transplantation; 2002 Oct; 74(7):951-60. PubMed ID: 12394836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection of mouse small bowel allografts by FTY720 and costimulation blockade.
    Yan S; Rodriguez-Barbosa JI; Pabst O; Beckmann JH; Brinkmann V; Förster R; Hoffmann MW
    Transplantation; 2005 Jun; 79(12):1703-10. PubMed ID: 15973172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia.
    La Mantia L; Prone V; Marazzi MR; Erminio C; Protti A
    Neurol Sci; 2014 Sep; 35(9):1485-6. PubMed ID: 24756193
    [No Abstract]   [Full Text] [Related]  

  • 31. Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
    Saab G; Almony A; Blinder KJ; Schuessler R; Brennan DC
    Arch Ophthalmol; 2008 Jan; 126(1):140-1. PubMed ID: 18195237
    [No Abstract]   [Full Text] [Related]  

  • 32. Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration.
    Massberg S; von Andrian UH
    N Engl J Med; 2006 Sep; 355(11):1088-91. PubMed ID: 16971715
    [No Abstract]   [Full Text] [Related]  

  • 33. FTY720: mechanism of action and potential benefit in organ transplantation.
    Brinkmann V
    Yonsei Med J; 2004 Dec; 45(6):991-7. PubMed ID: 15627289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.
    Brinkmann V; Chen S; Feng L; Pinschewer D; Nikolova Z; Hof R
    Transplant Proc; 2001; 33(1-2):530-1. PubMed ID: 11266942
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel mediators of FTY720 in human lymphocytes.
    Böhler T; Budde K; Neumayer HH; Waiser J
    Transplantation; 2005 Feb; 79(4):492-5. PubMed ID: 15729178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model.
    Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Omura T; Kishida A; Furukawa H; Todo S
    Transplant Proc; 1999; 31(1-2):1208-9. PubMed ID: 10083540
    [No Abstract]   [Full Text] [Related]  

  • 37. Blocking lymphocyte trafficking with FTY720 prevents inflammation-sensitized hypoxic-ischemic brain injury in newborns.
    Yang D; Sun YY; Bhaumik SK; Li Y; Baumann JM; Lin X; Zhang Y; Lin SH; Dunn RS; Liu CY; Shie FS; Lee YH; Wills-Karp M; Chougnet CA; Kallapur SG; Lewkowich IP; Lindquist DM; Murali-Krishna K; Kuan CY
    J Neurosci; 2014 Dec; 34(49):16467-81. PubMed ID: 25471584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fingolimod - a new immunomodulator].
    Friedrich FW; Eschenhagen T
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2127-31. PubMed ID: 19809964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
    Klatt J; Hartung HP; Hohlfeld R
    Nervenarzt; 2007 Oct; 78(10):1200-8. PubMed ID: 17668161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTY: not just a homely drug.
    Calne SR
    Transplantation; 2004 May; 77(9):1327. PubMed ID: 15167585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.